Global Hunter Securities got it right when the analysts set a “buy” rating and a $5.00 price target on Penny Stock ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC.OB) back on December 1, 2012. IMUC announced the ...
Continue Reading →
1
FEB
FEB
0
Share